Alamar Biosciences, Inc. (California) (ALMR)
34.36
+1.90
(+5.85%)
USD |
NASDAQ |
Oct 02, 16:00
34.62
+0.26
(+0.76%)
Pre-Market: 20:00
Alamar Biosciences Price : 34.36 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 32.97 | 34.62 | 32.80 | 34.36 | 339922.0 |
| Oct 01, 2026 | 33.92 | 34.66 | 32.37 | 32.46 | 379208.0 |
| Sep 30, 2026 | 32.47 | 35.28 | 32.24 | 34.07 | 741823.0 |
| Sep 29, 2026 | 32.43 | 33.60 | 32.18 | 32.65 | 1.091M |
| Sep 28, 2026 | 32.71 | 33.17 | 31.94 | 32.61 | 224702.0 |
| Sep 25, 2026 | 33.40 | 33.97 | 32.60 | 32.80 | 297266.0 |
| Sep 24, 2026 | 32.15 | 33.71 | 31.68 | 33.20 | 527264.0 |
| Sep 23, 2026 | 33.22 | 33.68 | 32.06 | 32.14 | 353087.0 |
| Sep 22, 2026 | 34.83 | 35.49 | 32.52 | 33.22 | 455177.0 |
| Sep 21, 2026 | 35.20 | 35.66 | 33.93 | 35.05 | 614605.0 |
| Sep 18, 2026 | 31.76 | 37.76 | 31.76 | 34.85 | 2.028M |
| Sep 17, 2026 | 29.82 | 32.18 | 29.16 | 32.01 | 551837.0 |
| Sep 16, 2026 | 29.06 | 30.10 | 28.52 | 29.38 | 469449.0 |
| Sep 15, 2026 | 28.01 | 29.62 | 27.86 | 28.75 | 472727.0 |
| Sep 14, 2026 | 27.89 | 28.45 | 27.25 | 27.99 | 389423.0 |
| Sep 11, 2026 | 28.30 | 30.62 | 27.41 | 27.89 | 323878.0 |
| Sep 10, 2026 | 28.82 | 28.84 | 27.33 | 27.77 | 339997.0 |
| Sep 09, 2026 | 29.90 | 30.58 | 28.50 | 28.96 | 185828.0 |
| Sep 08, 2026 | 30.49 | 30.91 | 29.75 | 29.95 | 221552.0 |
| Sep 04, 2026 | 30.17 | 31.06 | 29.82 | 30.80 | 142949.0 |
| Sep 03, 2026 | 30.83 | 31.06 | 29.60 | 30.57 | 206974.0 |
| Sep 02, 2026 | 29.60 | 31.40 | 29.42 | 30.49 | 241144.0 |
| Sep 01, 2026 | 30.21 | 31.03 | 29.15 | 29.36 | 185086.0 |
| Aug 31, 2026 | 30.28 | 31.36 | 29.20 | 30.54 | 325925.0 |
| Aug 28, 2026 | 32.70 | 33.54 | 30.46 | 30.71 | 267641.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| 10X Genomics, Inc. | 93.50 |
| Personalis, Inc. | 16.28 |
| Adaptive Biotechnologies Corp. | 28.35 |
| Champions Oncology, Inc. | 4.94 |
| Medpace Holdings, Inc. | 599.47 |
Price Related Metrics
| PS Ratio | 28.12 |
| Price to Book Value | 7.621 |
| Earnings Yield | -2.07% |
| Market Cap | 2.384B |